Barnett, J A <br/><br/>
Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP).  [electronic resource] 

 -  British journal of clinical pharmacology  Feb 1989 
 - 257-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0306-5251 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2125.1989.tb05358.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--blood<br/>Orosomucoid--metabolism<br/>Protein Binding<br/>Quinidine--metabolism<br/>Recombinant Proteins<br/>Tumor Necrosis Factor-alpha--therapeutic use